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Original Article
Malaria and Pregnancy: the perspective in Pakistan
Maqsood A. Bhatti, Muhammad Azharuddin, Samreen Bhatti*, Muhammad Islam, Muhammad Aslam Khan
Department of Medicine, Aga Khan University, *Dow University of Health Sciences, Karachi.
Abstract
Objective: To study the effects of malaria on pregnancy outcome.
Methods: A case control study conducted on patients identified by ICD-9 coding system of the hospital medical
records. Demographic and clinical data recorded on standardized data sheet and analyzed using SPSS 11.5
software.
Results: Of the total patients, 67.4% were multigravid and 32.6% were primigravid with 78.6% of patients hav-
ing platelets <150,000. Mean haemoglobin was 9.4 gm/dl in patients and 12.2 gm/dl in controls. Plasmodium
Vivax was accounted for 55.8%, P. Falciparum for 41.9%, and P. Ovale 2.3% of infections. In all, 48.8% of
patients received oral Chloroquine, 16.3% oral Quinine, 30.3% intravenous Quinine, 20.9% of patients received
combination treatment with IV Clindamycin, and one each patient received oral Artemether or oral halofantrine.
Two patients had an abortion. One of the following complications including, threatened abortion, preterm labour,
ARDS or Cerebral malaria, was observed in one patient each. Mean weight of babies born to cases was 2.8 kg
(range 1.4-3.8) and of control babies was 3.2 kg (range 2.5-4.0 kg). No congenital malformations were reported. 
Conclusion: Plasmodium  falciparum sp, moderate parasitic load, haemoglobin < 10 gm / dL, platelet count <
50,000 / mm3 and IV quinine with loading dose of 20 mg / kg are identified as few of the potential risk factors for
poor outcome in pregnancy (JPMA 57:15;2007).
Introduction
Malaria is hyperendemic in Pakistan, with the major-
ity of infections caused by Plasmodium vivax, although
infections with Plasmodium falciparum are increasing and
account for about 35--40% of cases.1 Malaria in pregnant
women is widely evaluated in sub-Saharan Africa, where
90% of global burden of malaria and deaths from disease
occur.2 Various studies have shown that pregnant women in
endemic areas are highly susceptible to malaria and both the
frequency and the severity of the disease is higher in preg-
nant than non-pregnant women.3-5 This higher susceptibili-
ty has been hypothesized to be due to transient depression
of cell mediated immunity which improves with delivery of
neonate and decreases with number of subsequent pregnan-
cies.6 It is also known that parasite density and prevalence
of anaemia are highest among primary gravida and decreas-
es with subsequent pregnancy and hence complication rates
are higher in primary gravida as compared to multi-gravida
patients.5,7-8 Malaria in pregnancy is significantly associat-
ed with higher mortality and morbidity including, cerebral
malaria, maternal anaemia, intrauterine growth retardation,
premature labour, stillbirth  and abortion.5,9 In addition;
drugs used for treatment of malaria can also contribute sig-
nificantly to complications associated with this disease. 
Pakistan is an endemic country for malaria. We pres-
ent here the data of a case control study on malaria during
pregnancy done in a tertiary care hospital of Pakistan.
Patients and Methods
A retrospective case control study was conducted at
Aga Khan University Hospital (AKUH), Karachi. AKUH is
a 502 bedded private, tertiary care, academic teaching hos-
pital that primarily serves the residents of Karachi (popula-
tion ~ 8-12 million) and the surrounding Sindh province.
Patients included in the study were adult (age > 15
years) pregnant women diagnosed with malaria, admitted at
AKUH between January 1999 to December 2003.  Women
with malaria during peripartum period were excluded.
Controls were randomly selected from pregnant
patients without malaria who were admitted for routine
delivery at Aga khan University Hospital in the period of
the study.
Three different kinds of variables were recorded on
data sheet. These included demographic variables, severity
related variables (parasite species, parasite load, supportive
lab values, length of hospital stay, pregnancy and malaria
related complications, maternal and foetal mortality etc),
and miscellaneous variables (parity, week of pregnancy,
week of delivery, Apgar score, baby weight etc)
Definitions: Maternal anaemia was defined as haemoglobin
< 11 g / dL, low birth weight as weight < 2500 g, preterm
labour was delivery before completing 37 weeks of preg-
nancy, and abortion (miscarriage) as complete expulsion of
product of conception before completing 28 weeks of gesta-
tion. Intrauterine growth retardation was labeled as per
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physician assessment. Parasite load was defined as scanty if
load was 1-10 parasites / high power (100) oil immersion
field (hpf), moderate if load was 11-100 / hpf, and heavy if
it was > 100 / hpf. 
Selection of treatment regimen was based on indi-
vidual physician's assessment and choice.
Statistical Analysis: Patients were identified according to
ICD - 9 - CM codes (647.4 & 650). Pregnant patients admit-
ted with malaria were taken as cases and pregnant patients
without malaria were taken as control. Data was recorded
on standardized data sheet and analyzed on SPSS 11.5 soft-
ware. The descriptive analysis was done for demographic
and clinical features. Results are expressed as mean + stan-
dard deviation for continuous variables and number (per-
centage) for categorical variables. Univariate analysis was
performed by using the Independent Sample t-test corre-
sponding to difference of means and Pearson Chi-square or
Fisher's exact test corresponding to proportion whenever
appropriate. Odds ratio (OR) and 95% CI (Confidence
Interval) were estimated to identify the strength of associa-
tion with independent factors. P-value     < 0.05 was consid-
ered as statistically significant and all         p-values are two
sided. Multivariate analysis was not done due to small total
number of cases.
Results
A total of 43 pregnant patients were identified with
malaria and 43 pregnant women without malaria were taken
as control. Mean age of cases was 26.9 ± 4.7 (range 18-38)
years and in control patient was 25.5 ± 4.5 (range 19- 40)
years. Only 14 (32.6%) were primary gravida, and 29
(67.4%) were multigravida (Table 1). Twenty four (55.8%)
patients presented in 3rd trimester, 11 (25.6%) in second
trimester and 8 (18.6%) presented in 1st trimester of preg-
nancy. P. Vivax accounted for 55.8% P. Falciparum for 41.9
%, and P. Ovale for 2.3% of infections. Twenty four (55.8%)
patients had moderate, 18 (41.9%) had scanty and 1 (2.3%)
had heavy parasitic load. Fever was present in  43 (100%)
patients while nausea and vomiting in 20 (46.5%) and myal-
gia in 10 (23.3%) patients. Mean haemoglobin was 9.4 ± 1.6
gm / dL (range 5.4 - 12.8 mg / dL) in cases and 12.2 ± 0.8
g / dL (range 11.0 - 14.4 mg / dL) in controls (P-value
<0.001).  Six (14%) patients had haemoglobin in the range
of 5-7.9 mg / dL (Table 2). Thirty three (78.6%) patients had
platelets < 150,000 / mm3, among them 6 (14%) patients
Table 2. Malaria associated complications¹ with different risk factors.
Factors
Compli-
cation
n (%)
No-Compli-
cation
n (%)
P--value OR (95% C.I)
Gravida
* Multi gravida
* Primary gravida
Platelets
* < 50,000
* > 50,000
Parasite sp.
* Falciparum
* Vivax / ovale
Parasite load
* Scanty
* Moderate
Quinine with loading 
dose
* Given
* Not given
8 (89)
1 (11)
4 (44)
5 (56)
7 (78)
2 (22)
4 (44)
5 (56)
3 (33)
6 (67)
21 (62)
13 (38)
2 (6)
31 (94)
11 (32)
23 (68)
14 (41)
20 (59)
3 (9)
31 (91)
0.231
0.013
0.023
0.999
0.095
4.9 (0.5--44.3)
†1
12.4 (1.8--88.6)
†1
7.3 (1.3--41.2)
†1
1.1  (0.3--5.0)
†1
5.2 (0.8--32.0)
†1
† Reference category
OR = Odds ratio
C.I = Confidence interval
1. Complications include: Abortion, preterm labor, low birth weight baby, intrauterine growth retar-
dation, ARDS, cerebral malaria
Table 1. Case control comparison of different variables.
Factors
Cases
(n=43)
Baby
(n=22)
Control
(n=43)
Baby
(n=43)
P--value
Age (in years)
Gravida
Primary
Multi
Apgar Score
1 minute
5 minutes
Baby Weight (in kg)
Baby Weight < 2500 gms
Mother Hemoglobin (g / dL)
26.9 ± 4.7
14 (32.6%)
29 (67.4%)
7.4 ± 1.0
8.7 ± 0.9
2.8 ± 0.7
7 (318%)
9.4 ± 1.6
25.5 ± 4.5
11 (25.6%)
32 (74.4%)
7.8 ± 0.7
8.9 ± 0.6
3.2 ± 0.3
-
12.2 ± 0.8
0.165
0.476
0.084
0.285
0.016
-
< 0.001
Results are presented as mean ± standard deviation and number (percentages).
Table 3. Complication rates in primary vs. multi-gravida patient.
Factors
Primi Gravida
n (%)
Multi-Gravida
n (%)
P--value
Platelets (per mm3)
* < 50,000
* > 50,000
Haemoglobin (g / dL)
Baby weight (in kg)
* < 2.5
* > 2.5
Abortion
* Yes
* No
2 (14)
12 (86)
10.9 ± 2.0
2 (11)
17 (89)
1 (4)
24(96)
4 (14)
25 (86)
10.8 ± 1.9
5 (11)
41 (89)
1 (2)
60 (98)
0.999
0.784
0.999
0.499
Results are presented as mean ± standard deviation and number (percentages).
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had platelets < 50,000 / mm3. The mean length of hospital
stay was 4.1 ± 1.7 days (range 1-8 days). 
Twenty one (48.8%) patients were treated with oral
Chloroquine, 7 (16.3%) with oral Quinine, 7 (16.3%)
received intravenous (IV) Quinine with loading dose of 20
mg / kg,6 (14%) received IV Quinine without loading dose,
9 (20.9%) had combination treatment with IV Clindamycin,
and one patient each received oral Artemether or oral halo-
fantrine. All patients with falciparum malaria were treated
with IV or oral Quinine with or without combination with
clindamycin except one who was treated with oral chloro-
quin and one with oral halofantrine. Most of the patient with
vivax malaria were given chloroquin except two, of whom
one each received quinine and artemether. Drug regimen
selection was based on individual physician’s choice. 
Twenty two out of 43 patients had babies born in
AKUH. Total number of babies in cases were lower because
some pregnant patients who were admitted in our hospital
for malaria, delivered their babies elsewhere and hence
remained unaccounted in our records. Mean weight of
babies in cases was 2.8 ± 0.7 kg (range 1.4-3.8 kg) and 3.2
± 0.3 kg (range 2.5- 4.0 kg) in control babies (P=0.016).
Seven babies were delivered with preterm labour, all were
< 2.5 kg in weight. Two patients had an abortion, one was
primary gravida and the other multigravida. One of the fol-
lowing complications including, threatened abortion,
ARDS, Cerebral malaria, and recurrence of falciparum
malaria was observed in one patient each. Recurrence of P.
falciparum was seen in a patient whose first episode was
treated with oral chloroquine. Specific risk factors including
parasite sp, parasite load, gravidity, thrombocytopenia and
IV quinine loading dose were identified in patients with
pregnancy and malaria associated complications (Table 2).
No congenital malformations in babies were report-
ed in charts except for one baby who was diagnosed with
Potters syndrome and died at age of 4 days, her mother was
suffering from polycystic kidney disease. This patient
received IV quinine without loading dose in combination
with IV Clindamycin during 14th week of pregnancy for
Falciparum malaria. 
Total seven patients received IV Quinine with load-
ing dose and two of them developed complete abortion dur-
ing treatment. Both patients had Falciparum sp. with mod-
erate parasitic load and platelet count of < 50,000 / mm3.
One pregnant patient died in third trimester with Adult res-
piratory distress syndrome secondary to severe malaria. 
Discussion
Malaria poses a serious health problem to pregnant
women. We have described important epidemiologic fea-
tures and clinical characteristics of 43 patients who had
malaria during pregnancy and compared some of the impor-
tant complications with control pregnant patients without
malaria.
In Pakistan, majority of infections in pregnant
patients are with P. Vivax sp., but complications of malaria
are mostly seen in P. falciparum sp. The incidence of sever-
ity of infection and pregnancy related complications varies
according to level of acquired immunity against infections
and the parity.10 In this study, the susceptibility to malaria
infection was high in multi-gravida  compared to primi-
gravida patients but associated complications were not sta-
tistically significant in both groups. This is in contrast to
various studies published from Indian subcontinent where
complication rate was higher in primary gravida compared
to multigravida patients.5,11,12 Falciparum malaria, moderate
parasitic load, haemoglobin < 10 mg / dL, platelet count <
50,000 / mm3, and use of IV quinine with loading dose of
20 mg / kg were identified as few of the potential risk fac-
tors for poor outcome of pregnancy. 
In highly endemic areas the peak level of falciparum
parasitemia occurs between 9 to 16 weeks of gestation and
then decreases progressively until delivery.5 In our study
55.8% of patients presented in  third trimester of pregnancy,
this is in contrast to previously reported higher incidence in
second trimester of pregnancy.5
One out of 43 patients died during hospitalization
due to underlying severe malaria and ARDS. She presented
in 30th week of pregnancy with scanty parasitic load of fal-
ciparum sp., haemoglobin was 8.5 gm / dl and platelet count
of 45000 / mm3. The mortality rate in our patients  was
much lower than previously reported figures from other
countries.5,12,13 Kochar et al associated significant anaemia
(Hb. 5 g%) as the prime cause of mortality in his cohort of
patients. In our patients malaria was significantly associat-
ed with haemoglobin decline of at least 2.8 gm compared to
control group ( P < 0.001), but it was not associated with a
higher mortality rate. The reason could be that in our group,
the severity of anaemia was much lower compared to the
cohort in Kochar's study with higher mortality.5
Placental malaria is a significant cause of pregnancy
related complications in the form of low birth weight
babies, preterm deliveries, still birth and abortion.5 In our
study, 7 pregnant patients had preterm live birth and all of
those babies were less than 2500 gm in weight. Overall
there was 400 gm decrease in birth weight of babies born to
pregnant women with malaria compared to pregnant patient
without malaria (P = 0.016). The biologic mechanism by
which placental malaria infection leads to low birth weight
is not fully established. P. falciparum infected placenta
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shows thickening of basement membrane of placental tro-
phoblast cells, potentially resulting in reduced nutrient
transfer to the foetus.14 Placental microinfarcts have been
reported; transplacental passage of parasitized RBC to foe-
tus does occur, and this may affect foetal nutrient use or
stimulate preterm labour.14
Limited data are available regarding spontaneous
abortion as a complication of clinical malaria or associated
anti-malarial drugs in therapeutic doses. In our study seven
patients received intravenous quinine with loading dose of
20 mg / kg body weight. Two of these patients aborted. One
was admitted with history of vaginal bleeding prior to treat-
ment  with quinine. The patients with abortion had some
common features like, falciparum malaria with moderate
parasitic load,  haemoglobin < 10g/dL and platelet count of
< 50,000 / mm3 and both patients received IV quinine with
loading dose. Various authors from other parts of the world
have reported that malaria is not an important cause of spon-
taneous abortion in highly endemic areas.4,5,11 Although
both of our patients had severe malaria; in one of the them
the loading dose of quinine might have precipitated com-
plete abortion from threatened abortion.  
Malaria has been a known cause of increased neona-
tal mortality.12 In the present study no significant foetal
mortality was observed among pregnant patients with
malaria compared to pregnant women without malaria
except for one baby who died due to Potters Syndrome
whose mother had a history of polycystic kidney disease.
One of the important limitations of our study was the
selection of patients.  Since our hospital is a tertiary care
private hospital, people belonging to the lower socioeco-
nomic class where malaria is more endemic, could not have
an easy access due to the cost factor. Hence the patient pop-
ulation studied cannot truly represent the general population
of Pakistan.
Conclusion
In our country malaria is more common in multi-
gravida and third trimester of pregnancy. It is significantly
associated with decreased maternal haemoglobin and low
birth weight of newborn. P. falciparum sp, moderate para-
sitic load, hb < 10 g/dL, platelet count < 50,000 / mm3, and
IV quinine with loading dose of 20 mg / kg are identified as
few of the potential risk factors for poor outcome in preg-
nancy. 
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